{
    "clinical_study": {
        "@rank": "40185", 
        "arm_group": [
            {
                "arm_group_label": "sugary dessert cream", 
                "arm_group_type": "Placebo Comparator"
            }, 
            {
                "arm_group_label": "maltitol alone", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "maltitol 85% / FOS 15%", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "maltitol 68% / FOS 32%", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "maltitol 50% / FOS 50%", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "FOS alone", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "Digestive symptoms following consumption of low digestibe carbohydrates are generally\n      assessed product by product but several ingredients can be used simultaneously. The study\n      aimed at evaluating to digestive tolerance of maltitol and FOS used in a same food."
        }, 
        "brief_title": "Digestive Tolerance of Maltitol and FOS", 
        "completion_date": {
            "#text": "November 2012", 
            "@type": "Actual"
        }, 
        "condition": "Digestive Tolerance in Healthy Adults", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  BMI between 18.5 and 30\n\n          -  normal and regular stool frequency: at least 3 stools per week and no more than 3 per\n             days\n\n          -  subjects not sufferinf from a metabolic, functional or inflammatory disease affecting\n             intestinal transit and nutrients absorption\n\n          -  subjects not sufferinf from IBS according to Rome III criteria\n\n          -  subjects not using mdeiction which could affect nutrients absoprtion\n\n        Exclusion Criteria:\n\n        -"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "36", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01909323", 
            "org_study_id": "SMALTO"
        }, 
        "intervention": [
            {
                "arm_group_label": "maltitol 85% / FOS 15%", 
                "intervention_name": "maltitol  85% / FOS15%", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "maltitol alone", 
                "intervention_name": "maltitol alone", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "maltitol 68% / FOS 32%", 
                "intervention_name": "maltitol 68% / FOS 32%", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "maltitol 50% / FOS 50%", 
                "intervention_name": "maltitol 50% / FOS 50%", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "FOS alone", 
                "intervention_name": "FOS alone", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "sugary dessert cream", 
                "intervention_name": "Placebo", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 25, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Saint-Herblain", 
                    "country": "France", 
                    "zip": "44800"
                }, 
                "name": "Biofortis SAS"
            }
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "6", 
        "official_title": "Digestive Tolerance and Postprandial Glycaemic and Insulinaemic Responses Evaluation of Different Maltitol/FOS Mixtures in Healthy Adults", 
        "overall_official": {
            "affiliation": "Biofortis SAS", 
            "last_name": "David Gendre, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Composite score of gastrointestinal symptoms in the 24h following the consumption of products", 
            "safety_issue": "Yes", 
            "time_frame": "24 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01909323"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Individual scores of gastrointestinal symptoms: bloating, abdominal discomfort, borborygms, flatulences", 
                "safety_issue": "Yes", 
                "time_frame": "24 and 48 hours"
            }, 
            {
                "measure": "Stool frequcency and consistency", 
                "safety_issue": "Yes", 
                "time_frame": "24 & 48 hours"
            }, 
            {
                "measure": "Glycaemic response", 
                "safety_issue": "No", 
                "time_frame": "2 hours"
            }
        ], 
        "source": "Syral", 
        "sponsors": {
            "collaborator": {
                "agency": "Beghin-Meiji", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Syral", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2011", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}